Spending $4 million on providing Covid-19 related products, long bank transfers process and IRCS' mission for imports of medicines and vaccines, inauguration of a production line for injectable medications and ...
Tehran, 20 June 2020- In response to the
questions of IRNA News Agency over IRCS' approach towards supplying and
procuring medicines and how IRCS cooperates with IFDA, Dr. Hemmati stated that
"We have a fine cooperation with Iranian FDA". He added that provision of
raw pharmaceutical materials and some other pharmaceutical products has always
been a concern for IRCS.